Petersohn Walter 4

4 · DENTSPLY SIRONA Inc. · Filed Nov 19, 2021

Insider Transaction Report

Form 4

Period: 2021-11-17

DENTSPLY SIRONA Inc.XRAY

Petersohn Walter

Chief Commercial Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−9,300→ 0 total
Exercise: $40.12Exp: 2028-08-09→ Common Stock (9,300 underlying)
Sale
Common Stock
2021-11-17$54.11/sh−17,748$960,291→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.09/sh−9,300$502,991→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.12/sh−9,134$494,359→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.30/sh−34,068$1,849,790→ 36,487.103 total
Sale
Common Stock
2021-11-17$54.08/sh−10,747$581,232→ 25,740.103 total
Exercise/Conversion
Common Stock
2021-11-17$40.12/sh+9,300$373,116→ 35,040.103 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−17,748→ 0 total
Exercise: $47.41Exp: 2024-11-25→ Common Stock (17,748 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−5,434→ 10,866 total
Exercise: $47.84Exp: 2030-03-04→ Common Stock (5,434 underlying)
Exercise/Conversion
Common Stock
2021-11-17$47.41/sh+17,748$841,433→ 43,488.103 total
Exercise/Conversion
Common Stock
2021-11-17$49.29/sh+9,134$450,215→ 34,874.103 total
Exercise/Conversion
Common Stock
2021-11-17$47.84/sh+5,434$259,963→ 31,174.103 total
Sale
Common Stock
2021-11-17$54.09/sh−5,434$293,947→ 25,740.103 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−9,134→ 4,566 total
Exercise: $49.29Exp: 2029-03-12→ Common Stock (9,134 underlying)

Footnotes (10)

[F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F10]Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F7]This option is fully vested and exercisable.
[F8]This option is fully vested and exercisable.
[F9]Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT